Fixing a broken treatment: new approach for rare bone disease
NCT ID NCT06015750
Summary
This study aimed to help patients with hypophosphatasia, a rare bone disorder, who started responding to their main treatment (asfotase alfa) but then lost that benefit. Researchers planned to test if adding immune-suppressing drugs could restore the treatment's effectiveness in these specific patients. The trial was withdrawn by the sponsor before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPOPHOSPHATASIA are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.